Monkeys respond well to Ebola vaccine in study

05/24/2010 | HealthDay News

A vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases appeared to protect cynomolgus macaque monkeys from three strains of the Ebola virus. "This finding will guide future vaccine design and may open an avenue for developing a single vaccine that works against both known and emerging Ebola virus species," said Anthony Fauci, director of the institute.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT